NorthWest Biotherapeutics Inc (NWBO)

[Dan88]

Why the title of the presentation at ASCO had been changed from including both D and L to only including D?

As I speculated in yahoo board (not post often now since I had tired of reading mostly useless posters some time ago. The same applies in this board), the events of 149 patients for the first interim analysis might have been reached just after the first time the title shown up in the public eye (thus the change of the title soon after).

are we waiting for DMC's recommendation now? !

If this is true, the price will continually climb for a couple of two more months until DMC comes up with a recommendation.

On the other hand, I also personally speculate that one or two Wall Street big names, either of investment firms or individual hedge fund/fund managers will be known to the public for taking a significant position besides UK's Woodford.

If either of these events happen, the price can easily go up to $20 and higher in a short period of time, excluding other major catalysts such as UK's final stage designation, HE price negotiation, D P2 launches, partnership deals with CI company...